You just read:

Bayer Submits New Drug Application for Radium Ra 223 Dichloride for the Treatment of Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases

News provided by

Bayer HealthCare Pharmaceuticals Inc.

14 Dec, 2012, 08:01 ET